Bio Ventures for Global Health introduces their expanded Global Health Primer. The Global Health Primer connects the capable innovators that drive research and development for new drugs, vaccines, and diagnostics to the neglected tropical diseases where innovation is desperately needed. In the 2011 update, we have significantly expanded the Primer to showcase more opportunities for those who want to make an impact on global health. Some highlights include:
- Creation of drug target and vaccine technology profiles in addition to the neglected disease profiles. These profiles group products in development by drug target classes and vaccine technologies that may span multiple diseases.
- Expansion of each disease profile to include drug target and vaccine technology analysis that spotlights opportunities for application to neglected tropical diseases.
- Greater analysis of strengths, weaknesses, opportunities, and risks for products currently in development for neglected tropical diseases, as well as information on development tools that are available to facilitate new product development.
You may access the Primer here: http://www.bvgh.org/Biopharmaceutical-Solutions/Global-Health-Primer.aspx.
Global Health Primer fact sheet.
For more information on BIO Ventures for Global Health, please visit www.bvgh.org.